Viking Therapeutics stock jumped higher last year because it looks like a dual GLP-1/GIP agonist it's developing could ...

As previously reported, Scotiabank analyst George Farmer initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 ...

Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The ...

We recently published an article titled These 10 Companies Led Monday’s Downturn. In this article, we are going to take a ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

By contrast, Novo Nordisk is both the developer and seller of Wegovy, while Viking Therapeutics's VK2735 has posted impressive results in testing and is now in the later stages of development.

Viking Therapeutics Inc. dropped its share prices ... impressed by the strong results from its potential weight loss asset VK2735, which could potentially become a groundbreaking development ...